Washington University licensed the following patents to ProteXase Therapeutics:
Inhibitors of Growth Factor Activation Enzymes, James W. Janetka, Partha Karmakar, Zhenfu Han, Peter Harris. (Washington University School of Medicine), September 15, 2016, WO2016144654.
NOVEL INHIBITORS OF SERINE PROTEASES, James W. Janetka, Vishnu Damalanka. (Washington University School of Medicine), provisional filed June 25, 2019.